Ma, X
Zhou, P
Wong, S W
Warner, M
Chaulagain, C
Comenzo, R L
Article History
Received: 2 April 2016
Revised: 30 May 2016
Accepted: 8 June 2016
First Online: 20 June 2016
Competing interests
: Drs Comenzo, Ma and Zhou have a patent pending on the siRNA sequences used to knock down expression of the κ light chain constant region. Dr Comenzo has served as a consultant or advisor to Takeda Millennium and Janssen, and has received clinical research funding from Takeda Millennium, Janssen, Teva and Prothena Biotech. Drs Wong and Chaulagain and Ms Warner declare no conflict of interest.